Gabapentin Capsule
Product Images NDC 80425-0150

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

This appears to be a graph depicting the mean pain score over a period of several weeks, with a 4-week dose titration period followed by a 4-week fixed dose period. The graph compares the effects of a placebo versus a dose of gabapentin at 3600 mg/day. However, without additional context or labels, it is difficult to interpret the specific details and purpose of the graph.*

FDA Label Image

Fig 2

This text appears to be a chart or table showing a 4-week dose titration period and a fixed dose period, possibly related to a pain medication study. The chart includes dosages of a medication (potentially Gabapentin) and a placebo, as well as columns for mean pain score and weeks. Without further context or information, it is difficult to provide a detailed description of the text's content or purpose.*

FDA Label Image

Fig 3

FDA Label Image

Fig 4

FDA Label Image

Formula

FDA Label Image

Gabapentin 100mg Cap Qty 60 Ndc 80425 0150

FDA Label Image

Gabapentin 100mg Cap Qty 90 Ndc 80425 0150

This is a description of a package of Apentin 100mg capsules containing 90 capsules. The package was packed by a company called AAdvancnd and has a product code of 2001001222.*

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.